Pinnacle Wealth Planning Services’s Viking Therapeutics VKTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VKTX
Pinnacle Wealth Planning Services's VKTX Position: Q3 2026 in Review
Pinnacle Wealth Planning Services reduced its Viking Therapeutics (VKTX) stake by 1.3% in Q3 2026, selling an estimated $1.07K and leaving 2,402 shares worth $78.3K. The position accounts for 0.01% of the portfolio, ranked #1017.
Pinnacle Wealth Planning Services first reported a position in VKTX in Q2 2022 and has held it in 14 quarters since. The position peaked at $626K in Q1 2024. 444 funds tracked by Wall St. Rank hold VKTX as of Q3 2026.
- Pinnacle Wealth Planning Services held 2,402 shares of Viking Therapeutics worth $78.3K as of Q3 2026.
- Pinnacle Wealth Planning Services sold 31 Viking Therapeutics shares in Q3 2026, an estimated $1.07K.
- Viking Therapeutics made up 0.01% of Pinnacle Wealth Planning Services's portfolio in Q3 2026, its #1017 holding.
- Pinnacle Wealth Planning Services first reported a position in Viking Therapeutics in Q2 2022 and has held it in 14 quarters since.
- Pinnacle Wealth Planning Services's Viking Therapeutics position peaked at $626K in Q1 2024.
- 444 funds tracked by Wall St. Rank held Viking Therapeutics as of Q3 2026.
Based on Pinnacle Wealth Planning Services's 13F filing for Q3 2026, filed 27 Oct 2026.